[go: up one dir, main page]

KR830007552A - 3-(피리드-3- 또는 -4-일알킬) 인돌의 제조방법 - Google Patents

3-(피리드-3- 또는 -4-일알킬) 인돌의 제조방법 Download PDF

Info

Publication number
KR830007552A
KR830007552A KR1019810004911A KR810004911A KR830007552A KR 830007552 A KR830007552 A KR 830007552A KR 1019810004911 A KR1019810004911 A KR 1019810004911A KR 810004911 A KR810004911 A KR 810004911A KR 830007552 A KR830007552 A KR 830007552A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
coo
cooh
Prior art date
Application number
KR1019810004911A
Other languages
English (en)
Inventor
에드워드 크로쓰 피터
피터 딕킨슨 로저
Original Assignee
윌리암 존 윌슨
화이자 코포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 존 윌슨, 화이자 코포레이숀 filed Critical 윌리암 존 윌슨
Publication of KR830007552A publication Critical patent/KR830007552A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

내용 없음

Description

3-(피리드-3-또는-4-일알킬) 인돌의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 염기존재하에 일반식(Ⅱ) 화합물을 일반식(Ⅲ) 또는 일반식(Ⅳ)의 알킬화제와 반응시키고 경우에 따라서 다음 (a) 내지 (g)공정중 하나이상을 실시함을 특징으로 하는 일반식(Ⅰ) 화합물 및 그의 약학적으로 허용되는 염의 제조방법.
    (상기 구조식에서,
    R1은 수소, C1-C4알킬, C3-C7싸이클로알킬 또는 페닐이고,
    R2는 수소, C1-C4알킬, C1-C4알콕시 또는 할로이고,
    R3는 수소 또는 C1-C4알킬이고,
    X는 -(CH2)n- (이때 n은 1,2 또는 3),또는이고,
    Y는 -COOH, -COO(C4-C1알킬), -CONH2, -CN 또는 5-테트라졸릴이고,
    Z는 3- 또는 4-피리딜이고,
    Hal은 Cl,Br 또는 I이고,
    R4는 H 또는 CH3이고,
    Y1은 -CH 또는 -COO(C1-C4알킬)이다.
    (a) Y가 -COO(C1-C4알킬)인 일반식(Ⅰ)화합물을 가수분해시켜 Y가 -COOH인 일반식(Ⅰ)화합물로 전환시킴:
    (b) Y가 -COOH1인 일반식(Ⅰ) 화합물을 산할라이드 또는 이미다졸리드로 만든 다음 암모니아와 반응시켜 Y가 -CONH2인 일반식(Ⅰ) 화합물로 전환시킴;
    (C) Y가 -COOH인 일반식(Ⅰ) 화합물을 에스테르화시켜 Y가 -COO(C1-C4알킬)인 일반식(Ⅰ) 화합물로 전환시킴;
    (d) Y가 -CN인 일반식(Ⅰ) 화합물을 각각 약한 또는 강한 가수분해를 시켜 Y가 -CONH2또는 -COOH인 일반식(Ⅰ) 화합물로 전환시킴;
    (e) Y가 -CN인 일반식(Ⅰ) 화합물을 소듐아지드 및 염화암모늄과 반응시켜 Y가 5-테트라졸릴인 일반식(Ⅰ) 화합물로 전환시킴;
    (f) Y가 -COO(C1-C4알킬)인 일반식(Ⅰ) 화합물을 암모니아와 반응시켜 Y가 -CONH2인 일반식(Ⅰ) 화합물로 전환시킴; 및
    (g) 일반식(Ⅰ) 화합물을 통상의 공정에 따라 그의 약학적으로 허용되는 염으로 전환시킴.
  2. 특허청구범위 제1항에 있어서, 알킬화제로서 일반식(Ⅲ) 화합물을 사용하고 염기로서 소튬하이드리드를 사용함을 특징으로 하는 방법.
  3. 특허청구범위 제1항에 있어서, 알킬화제로서 일반식(Ⅳ) 화합물을 사용하고 염기로서 벤질트리메틸 암모늄하이드록사이드를 사용함을 특징으로 하는 방법.
  4. 특허청구범위 제1항 또는 2항에 있어서, 소듐하이드리드 존재하에 2-메틸-3-(3-피리딜메틸)인돌을 에틸브로모아세테이트와 반응시킨 다음 생성된 에스테르를 알카리 가수분해시켜 2-[2-메틸-3-(3-피리딜메틸) 인돌-1-일] 초산을 제조함을 특징으로 하는 방법.
  5. 특허청구범위 제1항 또는 2항에 있어서, 소듐하이드리드 존재하에 2,5-디메틸-3-(3-피리딜메틸)인돌을 에틸브로모아세테이트와 반응시킨 다음 생성된 에스테르를 알칼리 가수분해시켜 2-[2,5-디메틸-3-(3-피리딜메틸)인돌-1-일]초산을 제조함을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004911A 1980-12-15 1981-12-14 3-(피리드-3- 또는 -4-일알킬) 인돌의 제조방법 KR830007552A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
KR830007552A true KR830007552A (ko) 1983-10-21

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004911A KR830007552A (ko) 1980-12-15 1981-12-14 3-(피리드-3- 또는 -4-일알킬) 인돌의 제조방법

Country Status (22)

Country Link
US (1) US4363912A (ko)
EP (1) EP0054417B1 (ko)
JP (1) JPS57181082A (ko)
KR (1) KR830007552A (ko)
AR (1) AR229110A1 (ko)
AU (1) AU525296B2 (ko)
CA (1) CA1143737A (ko)
CS (1) CS228527B2 (ko)
DD (1) DD202290A5 (ko)
DE (1) DE3167879D1 (ko)
DK (1) DK552581A (ko)
ES (1) ES507960A0 (ko)
FI (1) FI814003L (ko)
GR (1) GR76355B (ko)
IE (1) IE51949B1 (ko)
IL (1) IL64534A0 (ko)
NO (1) NO814264L (ko)
PH (1) PH17576A (ko)
PL (1) PL133634B1 (ko)
PT (1) PT74123B (ko)
YU (1) YU293481A (ko)
ZA (1) ZA818665B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
CN1205207C (zh) * 1998-03-31 2005-06-08 药品发现学会公司 取代的吲哚链烷酸
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
AU2003297727A1 (en) * 2002-12-10 2004-06-30 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
CA2658496A1 (en) 2006-07-22 2008-01-31 Oxagen Limited 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-yl} acetic acid derivatives and esters thereof having crth2 antagonist activity
US7888336B2 (en) * 2007-09-24 2011-02-15 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
WO2009090414A1 (en) * 2008-01-18 2009-07-23 Oxagen Limited Compounds having crth2 antagonist activity
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
US8168673B2 (en) * 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
US20100022613A1 (en) * 2008-01-22 2010-01-28 Oxagen Limited Compounds Having CRTH2 Antagonist Activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (ko) * 1966-02-11 1967-06-19
FR7337M (ko) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
AU525296B2 (en) 1982-10-28
JPS57181082A (en) 1982-11-08
PT74123B (en) 1983-12-19
NO814264L (no) 1982-06-16
GR76355B (ko) 1984-08-06
DK552581A (da) 1982-06-16
PL234253A1 (en) 1983-05-23
CS228527B2 (en) 1984-05-14
US4363912A (en) 1982-12-14
PT74123A (en) 1982-01-01
PL133634B1 (en) 1985-06-29
EP0054417A1 (en) 1982-06-23
PH17576A (en) 1984-10-01
ES8308872A1 (es) 1983-10-01
AR229110A1 (es) 1983-06-15
DE3167879D1 (en) 1985-01-31
AU7848881A (en) 1982-06-24
DD202290A5 (de) 1983-09-07
ES507960A0 (es) 1983-10-01
IE812928L (en) 1982-06-15
IE51949B1 (en) 1987-04-29
ZA818665B (en) 1982-10-27
FI814003L (fi) 1982-06-16
YU293481A (en) 1984-10-31
IL64534A0 (en) 1982-03-31
CA1143737A (en) 1983-03-29
EP0054417B1 (en) 1984-12-19

Similar Documents

Publication Publication Date Title
KR830007552A (ko) 3-(피리드-3- 또는 -4-일알킬) 인돌의 제조방법
KR840001952A (ko) N-(4-(3-아미노프로필) 아미노부틸)-2-(ω)-과니디노-지방산-아미도)-2-치환된-에탄아미드 이들의 염 및 이들의 제조방법
EP0744400A3 (en) Process for the preparation of 4-trifluoromethylnicotinic acid
PL291470A1 (en) Method of obtaining novel urea derivatives
PH15864A (en) 2-(2-alkoxy-methyl)-2-hydroxy-6-7 benzomorphans and salts thereof
GB1542112A (en) Process for the preparation of 2-phenylethanol or derivatives thereof
IE41474L (en) Thiomethylergolines
KR850000438A (ko) 페녹시 유도체의 제조방법
ES8200643A1 (es) Derivador del acido ciclohexano carboxilico
KR890014435A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
US3979506A (en) Radioactive compounds for labeling proteins
KR850002459A (ko) 디히드록시벤즈아미드 유도체 및 그 제조방법
JPS5549352A (en) Cyclic iminocarboxylic acid derivative and its salt
JPS5551041A (en) Phenyl-fatty acid derivative
GB1432649A (ko)
IE792508L (en) Piperidylindoles
GB1446632A (en) 5-endo-benzoyloxy-n-amino-c2-4 alkyl- bicyclo-2,2,1-heptane - 2,3-d-endo-carboxylic acid imides
NZ503916A (en) Method of synthesis of pyrrole and indole amides
KR850001181A (ko) 아미노-n-(1h-테트라졸-5-일) 벤즈아미드의 카바메이트 및 옥살아미드의 제조방법
NZ508845A (en) Method for preparing pharmaceutically valuable norbenzomorphane derivatives
AU1010992A (en) Process for the preparation of 2,4,6-triiodo 5-amino- n-alkylisophthalamic acid
ES8401957A1 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
KR850004581A (ko) α,α-디메틸페닐아세트아닐리드 유도체의 제조방법
JPS57130972A (en) Preparation of indole derivative
IE831074L (en) Preparation of thiophene-2-acetic acids

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19811214

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination